Get the Stockscreener App
181.85
2.19%
-4.07
Pre-market:
175.27
-6.58
-3.62%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $181.85, with a volume of 1.73M.
It is down -2.19% in the last 24 hours and down -0.85% over the past month.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
See More
Previous Close:
$185.92
Open:
$185.18
24h Volume:
1.73M
Relative Volume:
0.85
Market Cap:
$49.53B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
46.11
EPS:
3.9437
Net Cash Flow:
$3.07B
1W Performance:
+1.14%
1M Performance:
-0.85%
6M Performance:
+13.46%
1Y Performance:
-2.34%
1-Day Range:
$181.29
$186.27
1-Week Range:
$175.20
$186.63
52-Week Range:
$140.11
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
181.85 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
382.29 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
RMD
Resmed Inc
|
228.25 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.30 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
32.99 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Did $40 Million Verdict Just Shift BD's (BDX) Investment Narrative? - simplywall.st
Becton Dickinson (BDX) Could Be 10% Undervalued As Dividend Lands - simplywall.st
Becton, Dickinson at Wells Fargo healthcare conference: focus sharpens - investing.com
Becton, Dickinson at Wells Fargo healthcare conference: focus sharpens By Investing.com - Investing.com UK
Transcript : Becton, Dickinson and Company Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 through Sep-10-2026 - marketscreener.com
Becton Dickinson & Co's Dividend Analysis - Yahoo Finance Singapore
Is Becton Dickinson & Co (BDX) a Bargain After 3.0% Drop? GF Val - GuruFocus
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton Dickinson & Co To Go Ex-Dividend On September 9th, 2026 With 1.05 USD Dividend Per Share - Moomoo
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 5.91% Potential Upside in the Healthcare Giant - DirectorsTalk Interviews
How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance
BECTON DICKINSON & CO CFO Roque Vitor Retains 8,041 Shares Following 190-Share Forfeiture - Kalkine Media
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Becton Dickinson (NYSE: BDX) CFO reports 190-share tax withholding - Stock Titan
Quote and Chart - Becton Dickinson
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - Moomoo
Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth with a Solid Dividend Yield and Potential Upside - DirectorsTalk Interviews
Becton Dickinson and Company (BDX) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Becton Dickinson (BDX) Hits STANCE Trial Milestone, Is The Stock Fully Valued? - simplywall.st
BD trial reaches 274 patients studying breast implant scar tissue - Stock Titan
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
A continuous monitoring medtech vet charts the course to a less-invasive future - Medical Design & Outsourcing
16,962 Shares in Becton, Dickinson and Company $BDX Acquired by Wealthfront Advisers LLC - MarketBeat
Park West Asset Management LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Tocqueville Asset Management L.P. Raises Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Flossbach Von Storch SE Sells 8,875 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson stock extends its August rally as shares trade close to 52-week high - Ad-hoc-news.de
Danske Bank A S Decreases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Foster & Motley Inc. Purchases New Position in Becton, Dickinson and Company $BDX - MarketBeat
A Look at Becton Dickinson & Co (BDX) After 3.8% Gain -- GF Value $190.44 vs Price $187.60 - GuruFocus
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson and Co stock hits 52-week high at 187.5 USD - Investing.com Nigeria
Becton, Dickinson and Company (NYSE:BDX) Reaches New 1-Year HighWhat's Next? - MarketBeat
What's Going On With Becton Dickinson Stock Wednesday? - Benzinga
Mitsubishi UFJ Asset Management Co. Ltd. Makes New Investment in Becton, Dickinson and Company $BDX - MarketBeat
Pallas Capital Advisors LLC Takes $920,000 Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Great Lakes Advisors LLC - MarketBeat
Deutsche Bank AG Purchases Shares of 1,349,544 Becton, Dickinson and Company $BDX - MarketBeat
BlackRock Inc. Purchases Shares of 24,592,166 Becton, Dickinson and Company $BDX - MarketBeat
BD appoints Gary Sorsher as EVP and chief quality officer - MassDevice
BD names Gary Sorsher as CQO - Medical Buyer
K.J. Harrison & Partners Inc Takes $1.59 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Nuance Investments LLC Acquires Shares of 96,615 Becton, Dickinson and Company $BDX - MarketBeat
Trust Co. of Vermont Takes $4.99 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Plato Investment Management Ltd Purchases Shares of 11,485 Becton, Dickinson and Company $BDX - MarketBeat
OneDigital Investment Advisors LLC Purchases Shares of 8,473 Becton, Dickinson and Company $BDX - MarketBeat
Commerzbank Aktiengesellschaft FI Invests $2.39 Million in Becton, Dickinson and Company $BDX - MarketBeat
Flputnam Investment Management Co. Takes $1.52 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
7,783 Shares in Becton, Dickinson and Company $BDX Purchased by Global Retirement Partners LLC - MarketBeat
Early Alert: Convenience Kit Issue from Becton Dickinson - fda.gov
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire - Finviz
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
2.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):